Website value calculator & SEO Checker => keytruda.com

Q: What IP keytruda.com has?

The domain keytruda.com has IP 18.66.218.27 . An IP address is a string of numbers used to make devices accessible for communication.

SEO report with information and free domain appraisal for keytruda.com. It is a domain hosted in . Its server is hosted on IP 18.66.218.27. The domain is ranked at the number 450866 as a world ranking of web pages. According to estimated data we have access to potential gains of this site are 120 dollars per month. In annual terms, the domain keytruda.com could be earning more than 1440 dollars. If someone wanted to buy the domain a good selling price would be 14402 dollars.

These data are estimated and can not be taken as 100 % real. Only give an estimate of profits depending on the subject and the traffic generated by keytruda.com . The estimated number of unique visitors accessing keytruda.com is 1049. Thus the total number of people who visit this page per month would be 31460 people.

Domain Authority

SEO Score

☰ Report Resume

Page Speed Score
Speed
Page Load Time
Current Ip of the domain: 18.66.218.27
Charset of page: UTF-8
Total Keywords: 3045
Total Links:

Anchor text
Type
Link
Indication
follow
#indication
Important Safety Information
follow
#isi
Medication Guide
follow
https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf
Prescribing Information
follow
https://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf
View Health Care Professionals Site
follow
https://www.keytrudahcp.com/

follow
/
Cancer Type
follow
#
Sign Up for Support
follow
/key-you-sign-up/
Chat
follow
javascript:void(0)
Results From Clinical Trials
follow
/clinical-trial-results/
About KEYTRUDA
follow
#
How does KEYTRUDA work?
follow
/how-does-keytruda-work/
Side effects
follow
/side-effects/
Patient stories with KEYTRUDA
follow
/patient-stories/
Taking KEYTRUDA
follow
/taking-keytruda/
Frequently asked questions
follow
/keytruda-faq/
View patient stories
follow
/patient-stories/
Cost Info & Financial Help
follow
/financial-support/
Patient Support
follow
#
Starting KEYTRUDA
follow
/getting-started/
Patient support sign-up
follow
/key-you-sign-up/
Tips for managing treatment
follow
/immunotherapy-treatment-tips/
85-KEYTRUDA(855-398-7832)
follow
tel:+18553987832
Chat
follow
javascript:void(0)
Advanced non–small cell lung cancer
follow
/non-small-cell-lung-cancer/
Melanoma
follow
/melanoma/
Head and neck squamous cell cancer
follow
/head-and-neck-cancer/
High-risk non-muscle invasive bladder cancer (NMIBC)
follow
/non-muscle-invasive-bladder-cancer/
Advanced kidney cancer (RCC)
follow
/advanced-kidney-cancer/
Advanced MSI-H/dMMR colorectal cancer
follow
/msi-h-dmmr-colorectal-cancer/
Microsatellite instability-high cancer (MSI-H/dMMR)
follow
/msi-h/
High-risk early-stage triple-negative breast cancer (TNBC)
follow
/high-risk-early-stage-tnbc/
Advanced triple-negative breast cancer (TNBC)
follow
/triple-negative-breast-cancer/
Classical Hodgkin lymphoma (cHL)
follow
/classical-hodgkin-lymphoma/
Advanced gastric cancer
follow
/gastric-cancer/
Advanced cervical cancer
follow
/cervical-cancer/
Primary mediastinal B‑cell lymphoma (PMBCL)
follow
/primary-mediastinal-b-cell-lymphoma/
Advanced liver cancer (HCC)
follow
/advanced-hepatocellular-liver-cancer/
Advanced Merkel cell carcinoma
follow
/merkel-cell-carcinoma/
Advanced esophageal cancer
follow
/esophageal-cancer/
Cutaneous squamous cell carcinoma (cSCC)
follow
/squamous-cell-skin-cancer/
Side effects
follow
/side-effects/
See how KEYTRUDA works
follow
/how-does-keytruda-work/
Patient support
follow
/key-you-sign-up/
View patient stories
follow
/patient-stories/
Sign up for support
follow
/key-you-sign-up/
Learn about The Merck Access Program
follow
https://www.merckaccessprogram-keytruda.com
Call 855-257-3932
follow
tel:+18552573932

follow
/
(advanced melanoma)
follow
/melanoma/
non–small cell lung cancer (NSCLC)
follow
/non-small-cell-lung-cancer/
(advanced NSCLC)
follow
/non-small-cell-lung-cancer/
nonsquamous
follow
/non-small-cell-lung-cancer/combination-therapy-clinical-trial-results/
(advanced NSCLC)
follow
/non-small-cell-lung-cancer/
squamous
follow
/non-small-cell-lung-cancer/clinical-trial-results/
(advanced NSCLC)
follow
/non-small-cell-lung-cancer/
PD-L1
follow
/keytruda-faq/#what-are-pd1-and-pdl1
advanced NSCLC
follow
/non-small-cell-lung-cancer/
head and neck squamous cell cancer (HNSCC)
follow
/head-and-neck-cancer/
PD-L1
follow
/keytruda-faq/#what-are-pd1-and-pdl1
classical Hodgkin lymphoma (cHL)
follow
/classical-hodgkin-lymphoma/
primary mediastinal B-cell lymphoma (PMBCL)
follow
/primary-mediastinal-b-cell-lymphoma/
(high-risk, non-muscle invasive bladder cancer [NMIBC])
follow
/non-muscle-invasive-bladder-cancer/
microsatellite instability-high (MSI-H)
follow
/msi-h/
(advanced colon or rectal cancer)
follow
/msi-h-dmmr-colorectal-cancer/
(advanced gastric cancer)
follow
/gastric-cancer/
esophageal or certain gastroesophageal junction (GEJ) carcinomas
follow
/esophageal-cancer/
cervical cancer
follow
/cervical-cancer/
hepatocellular carcinoma
follow
/advanced-hepatocellular-liver-cancer/
Merkel cell carcinoma (MCC)
follow
/merkel-cell-carcinoma/
renal cell carcinoma (RCC)
follow
/advanced-kidney-cancer/
cutaneous squamous cell carcinoma (cSCC)
follow
/squamous-cell-skin-cancer/
(high-risk early-stage triple-negative breast cancer [TNBC])
follow
/high-risk-early-stage-tnbc/
(advanced TNBC)
follow
/triple-negative-breast-cancer/
PD-L1
follow
/keytruda-faq/#what-are-pd1-and-pdl1
www.fda.gov/medwatch
follow
https://www.fda.gov/Safety/MedWatch/default.htm
1-800-FDA-1088
follow
tel:800-332-1088
Medication Guide
follow
http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf
Prescribing Information
follow
http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf

follow
/
How does KEYTRUDA work?
follow
/how-does-keytruda-work/
Side effects
follow
/side-effects/
Patient stories with KEYTRUDA
follow
/patient-stories/
Taking KEYTRUDA
follow
/taking-keytruda/
Frequently asked questions
follow
/keytruda-faq/
Results from clinical trials
follow
/clinical-trial-results/
Starting KEYTRUDA
follow
/getting-started/
Patient support sign-up
follow
/key-you-sign-up/
Tips for managing treatment
follow
/immunotherapy-treatment-tips/
Cost info & financial help
follow
/financial-support
Indications
follow
#indication
Important safety information
follow
#isi
Privacy Policy
follow
https://www.msdprivacy.com/us/en/index.html
Terms of Use
follow
https://www.merck.com/policy/terms-of-use/home.html
Cookie Preferences
follow
javascript:void(0)
View Health Care Professionals Site
follow
https://www.keytrudahcp.com/

follow
//privacy.truste.com/privacy-seal/validation?rid=140649f5-9394-46e8-bfe5-b4ea8a8c600e

follow
//privacy.truste.com/privacy-seal/validation?rid=11c1aa82-b7e7-4a2f-b02e-ba935e661720
Advanced non–small cell lung cancer
follow
/non-small-cell-lung-cancer/
Melanoma
follow
/melanoma/
Head and neck squamous cell cancer
follow
/head-and-neck-cancer/
High-risk non-muscle invasive bladder cancer (NMIBC)
follow
/non-muscle-invasive-bladder-cancer/
Advanced kidney cancer (RCC)
follow
/advanced-kidney-cancer/
Advanced MSI-H/dMMR colorectal cancer
follow
/msi-h-dmmr-colorectal-cancer/
Microsatellite instability-high cancer (MSI-H/dMMR)
follow
/msi-h/
High-risk early-stage triple-negative breast cancer (TNBC)
follow
/high-risk-early-stage-tnbc/
Advanced triple-negative breast cancer (TNBC)
follow
/triple-negative-breast-cancer/
Classical Hodgkin lymphoma (cHL)
follow
/classical-hodgkin-lymphoma/
Advanced gastric cancer
follow
/gastric-cancer/
Advanced cervical cancer
follow
/cervical-cancer/
Primary mediastinal B‑cell lymphoma (PMBCL)
follow
/primary-mediastinal-b-cell-lymphoma/
Advanced liver cancer (HCC)
follow
/advanced-hepatocellular-liver-cancer/
Advanced Merkel cell carcinoma
follow
/merkel-cell-carcinoma/
Advanced esophageal cancer
follow
/esophageal-cancer/
Cutaneous squamous cell carcinoma (cSCC)
follow
/squamous-cell-skin-cancer/
Side effects
follow
/side-effects/
See how KEYTRUDA works
follow
/how-does-keytruda-work/
Patient support
follow
/key-you-sign-up/
Medication Guide
follow
http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf
Prescribing Information
follow
http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf
Return to site
follow
/high-risk-early-stage-tnbc/
Social signals
Title: 26 characters.
Description: 99 characters.
Domain Authority
Monthly pages viewed: 31460
Estimated worth: 14402 dollars

☷ Major sections

❀ Whois

We have developed a useful service for retrieve WhoIs information. "Whois" is a term that begins from the early days of the Internet, based on Unix operating system and university networks. On the Unix console, the command "whois" tries to determine the identity of the domain's registrant.

It is a means for Internet users to query various types of information such as IP addresses, user data and also domain data.

✦ SEO Report

Title / Meta tags

KEYTRUDA® (pembrolizumab)

Learn about how KEYTRUDA® (pembrolizumab) works as an immunotherapy to help fight certain cancers.

Image Analysis

A right example for an HTML image tag:

For SEO performance, you must write an alternative text. The alternative text must describe the image's content. Also, the alt tag is used for blind people. Their browsers tell them all about the description of the image.

Heading

Content Analysis

Code Analysis

We have not found hyphens (-) or underscores (_) in your URL. Google and expert domainers do not recommend buying domains with hyphens or underscores.

☛ Speed Analysis

When a visitor came to your website you can not fail. The user wants your page to load in a second. You know that it is difficult sometimes to display content in the first second but if the user has to wait too much time you can lose that user. If your page is too slow, you will lose a lot of web traffic. Your project URL load time is ms, it is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.keytruda.com is as follows:

A huge portion of visitors to your website are usually in rush and nobody is fond of waiting too much before your website loads its content. If your website is slow, you will lose a lot of visitors. Your homepage load time is ms is class speed. This speed not fine and need to be improved. It is over the average. Our Speed analyzer has shown that www.keytruda.com is as follows:

Speed:

Page Load Time: ms

⚐ Page Analysis

⚏ CSS Class names

base , top-wrapper, header , header__wrapper, header__cancer-selection-container, header__select-cancer-button, header__nav-container, header__nav-item header__nav-item--indication-link, anchor-smooth-scroll, header__nav-item, header__nav-item header__nav-item--hcp-link, main-nav , container main-nav__container, main-nav__logo-container, link main-nav__logo-link, main-nav__universal-links-container, main-nav__universal-links-list, main-nav__universal-link-item main-nav__universal-link-item--cancer-select, main-nav__universal-link-icon-wrapper, main-nav__universal-link-icon-image, main-nav__universal-link-item, main-nav__universal-link-item main-nav__universal-link-item main-nav__universal-link-item--chatbot chatbot-launcher__trigger, main-nav__universal-link-item main-nav__universal-link-item--hamburger-menu, main-nav__universal-button main-nav__universal-button--hamburger-menu, main-nav__primary-drawer-container highlight-, main-nav__primary-links-list, main-nav__primary-link-item , main-nav__primary-link , main-nav__primary-link-icon-wrapper, main-nav__primary-link main-nav__primary-link--secondary-toggle, main-nav__secondary-container, main-nav__secondary-col main-nav__secondary-col--5 main-nav__secondary-col--order-first, main-nav__secondary-back-button-container, main-nav__secondary-back-button, main-nav__secondary-title, main-nav__secondary-links-list, main-nav__secondary-link-item, main-nav__secondary-link link-underline, main-nav__secondary-col main-nav__secondary-col--off-white main-nav__secondary-col--7 main-nav__secondary-col--order-second, main-nav__secondary-callout-container, main-nav__secondary-callout-copy-wrapper text-container, font-header-4, main-nav__secondary-callout-links-wrapper, main-nav__secondary-callout-links, tertiary-action-button, tertiary-action-button__link, tertiary-action-button__text, main-nav__secondary-callout-image, dpi-2, visible-lg, main-nav__secondary-col main-nav__secondary-col--5 main-nav__secondary-col--order-second, main-nav__secondary-col main-nav__secondary-col--off-white main-nav__secondary-col--7 main-nav__secondary-col--order-first, no-line-break, main-nav__primary-link-item main-nav__primary-link-item--chatbot chatbot-launcher__trigger, page-section page-section--hero-banner-full page-section--relative background-color-off-white, page-section__container page-section__container--static, page-section__content, column-section hero-banner-full column-section--5-7, column-section__container hero-banner-full__container, column-section__area column-section__area--full-bleed column-section__area--second column-section__area--end, hero-banner-full__desktop-image-wrapper, hero-banner-full__mobile-image-wrapper, column-section__area column-section__area--first column-section__area--center column-section__area--relative, text-container hero-banner, hero-banner-full__text, font-header-1, font-header-3, page-section page-section--background-key-green page-section--margin-top-0 , page-section__container, cancer-search, cancer-search__container, cancer-search__top, cancer-search__top-heading, cancer-search__input-container, cancer-search__input, cancer-search__input-clear, cancer-search__content-container-outer-wrapper, cancer-search__content-container, cancer-search__list, cancer-search__list-item, selector-action-button, selector-action-button__link , selector-action-button__text, no-wrap, cancer-search__tags, cancer-search__no-results-container, cancer-search__no-results-heading, cancer-search__no-results-list-container, cancer-search__no-results-list-heading, cancer-search__no-results-list, cancer-search__no-results-list-item, tertiary-action-button__link , cancer-search__go-back-button, page-section , column-section callout-a-1 column-section--6-6 column-section--border-key-green, column-section__container callout-a-1__container, column-section__area column-section__area--first column-section__area--center callout-a-1__area callout-a-1__area--first, icon-block callout-a-1__icon-block, icon-block__icon-container callout-a-1__icon-container, icon-block__content-container callout-a-1__icon-content-container, text-container icon-block-text-container, font-header-2, primary-action-button, primary-action-button__link , primary-action-button__text, column-section__area column-section__area--second column-section__area--end callout-a-1__area callout-a-1__area--second, image , image__embed-container, image__embed image__embed--callout-a-1, column-section callout-c-1 column-section--5-7 column-section--border-light-grey, column-section__container callout-c-1__container, column-section__area column-section__area--first column-section__area--hide-mobile column-section__area--end callout-c-1__area callout-c-1__area--first, image__embed image__embed--callout-c-1, column-section__area column-section__area--second column-section__area--center callout-c-1__area callout-c-1__area--second, text-container callout-c-1, column-section callout-a-3 column-section--7-5 column-section--border-key-green, column-section__container callout-a-3__container, column-section__area column-section__area--first column-section__area--center callout-a-3__area callout-a-3__area--first, column-section__area column-section__area--second column-section__area--center callout-a-3__area callout-a-3__area--second, icon-block callout-a-3__icon-block, icon-block__icon-container callout-a-3__icon-container, icon-block__content-container callout-a-3__icon-content-container, link, indications-and-safety, indications-and-safety__anchor-wrapper, indications-and-safety__container, indications-and-safety__logo-wrapper, indications-and-safety__logo, indications-and-safety__content, indications__container, indications__content, indications__content-title, indications-and-safety__copy, indications-and-safety__list, indications-and-safety__list-item, indications-and-safety__list-item indications-and-safety__list-item--sublist indications-and-safety__list-item--sublist-1, indications-and-safety__list-item indications__list-item--margin-top-ssi, nolink-on-cookie no-line-break, indications-and-safety__list-item indications-and-safety__list-item--sublist indications-and-safety__list-item--sublist-2, indications-and-safety__list-item indications__list-item--no-bullet, indications-and-safety__copy indications-and-safety__copy--footnote, safety__anchor-wrapper, safety__container, safety-information, safety-information__title, safety-information__content, strong, footer, footer__container, footer__top, footer__column, footer__column-logo, footer__sub-column, footer__column-header, footer__link-list, footer__link-list-item, footer__link-list-link, footer__bottom, footer__bottom-top, footer__horizontal-list, footer__horizontal-list-item, footer__horizontal-list-link, footer__horizontal-list-link ot-sdk-show-settings, footer__hcp-link-button, footer__bottom-bottom, footer__paragraph-text, footer__bottom-logos, footer__bottom-truste-container, footer__truste-link, footer__bottom-merck-container, footer__merck-logo, chatbot-launcher, chatbot-launcher__container, chatbot-launcher__button chatbot-launcher__trigger, chatbot-launcher__icon, chatbot-launcher__button-text, modal , modal__container, modal__close-button, sr-only, text-container , back-action-button, back-action-button__link , back-action-button__text,

Ω HTTP Header Analysis

✪ Source Analysis

Your website is made from CSS files, images and javascript sources. We count all the files and their size. This is vital data about the performance of your website.